Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07393204
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* Patients registered in the Cnn program of epcoritamab (between February 19, 2024 and September 25, 2024)
* Received at least one dose of epcoritamab
* Free and voluntary written informed consent
Exclusion Criteria:
* Age \< 18 years
* Patients who received epcoritamab outside the Cnn program (e.g., open access program, compassionate use, off-label, prospective trials).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07393204
Study Brief:
Protocol Section:
NCT07393204